Pintér Tamás Bence

Publication list

Tudóstér co-authors statistics filterable publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2024-2026

2026

Enyedi, E. E., Szabó, A. Á., Pintér, T. B., Mányiné Siket, I., Pluhár, A., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Albumin-Bound Fatty Acids Modulate Endogenous Angiotensin-Converting Enzyme (ACE) Inhibition.
Biomedicines. 14 (1), 1-19, (article identifier: 103), 2026.

doi DEA

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q1 Medicine (miscellaneous) (2024)

2025

Szabó, A. Á., Enyedi, E. E., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Interference-Free Measurement of Urinary Angiotensin-Converting Enzyme (ACE) Activity: Diagnostic and Therapeutic Monitoring Implications.
Biomedicines. 13 (10), 1-17, (article identifier: 2528), 2025.

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q1 Medicine (miscellaneous) (2024)

2024

Szabó, A. Á., Enyedi, E. E., Altorjay, I., Hajnal, P., Pintér, T. B., Mányiné Siket, I., Váradi, C., Bányai, E., Tóth, A., Papp, Z., Fagyas, M.: Get reliable laboratory findings: how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?.
Clin. Chem. Lab. Med. 62 (7), 1393-1401, 2024.

Journal metrics:

Q1 Biochemistry (medical)

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)